Eviper D 4 mg/1.25 mg Tablet
By Eviper D
Rx
10 Tablet in a Strip

Composition
Perindopril erbumine(4mg) + Indapamide(1.25mg)

Manufacturer - Torrent Pharmaceuticals Ltd
Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Expires on or after
October, 2025

liver
When it comes to liver disease, caution is essential when using Eviper D 4 mg/1.25 mg Tablet. Patients with liver issues should be careful and seek advice from their doctor before taking this medication. It might be necessary to adjust the dosage of Eviper D 4 mg/1.25 mg Tablet in such cases. It is important to consult with your healthcare provider to ensure the safe and appropriate use of this tablet if you have liver disease.

kidney
Eviper D 4 mg/1.25 mg Tablet requires caution for patients with kidney disease. Dosage adjustments may be necessary. Consult your doctor if you have renal impairment.

alcohol
Eviper D 4 mg/1.25 mg Tablet can lead to increased drowsiness when combined with alcohol.

driving
Eviper D 4 mg/1.25 mg Tablet might impact your driving ability. While it typically does not affect alertness, some patients may experience dizziness or weakness from low blood pressure, which can hinder driving.

pregnancy
Eviper D 4 mg/1.25 mg Tablet is not recommended during pregnancy due to potential risks to the developing baby. Your doctor may only prescribe it in critical situations where benefits outweigh risks. Consult your doctor before use.

breastfeeding
Eviper D 4 mg/1.25 mg Tablet is likely safe during breastfeeding based on minimal data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹109
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024